-
1
-
-
0037237580
-
Chagas disease in a domestic transmission cycle, southern Texas, USA
-
Beard CB, Pye G, Steurer FJ, Rodriguez R, Campman R, Peterson AT, Ramsey J, Wirtz RA, Robinson LE. 2003. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg. Infect. Dis. 9:103-105. http://dx.doi.org/10.3201/ eid0901.020217.
-
(2003)
Emerg. Infect. Dis.
, vol.9
, pp. 103-105
-
-
Beard, C.B.1
Pye, G.2
Steurer, F.J.3
Rodriguez, R.4
Campman, R.5
Peterson, A.T.6
Ramsey, J.7
Wirtz, R.A.8
Robinson, L.E.9
-
2
-
-
77954187759
-
Chagas disease: A new worldwide challenge
-
Coura JR, Vinas PA. 2010. Chagas disease: a new worldwide challenge. Nature 465:S6-S7. http://dx.doi.org/10.1038/nature09221.
-
(2010)
Nature
, vol.465
-
-
Coura, J.R.1
Vinas, P.A.2
-
3
-
-
0142197130
-
Chagas disease: Current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries
-
Moncayo A. 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 98:577-591. http://dx.doi.org/10.1590/S0074- 02762003000500001.
-
(2003)
Mem. Inst. Oswaldo Cruz
, vol.98
, pp. 577-591
-
-
Moncayo, A.1
-
4
-
-
27744577051
-
High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina
-
Negrette OS, Mora MC, Basombrio MA. 2005. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 115:e668-e672. http://dx.doi.org/10.1542/peds.2004-1732.
-
(2005)
Pediatrics
, vol.115
-
-
Negrette, O.S.1
Mora, M.C.2
Basombrio, M.A.3
-
5
-
-
77953023715
-
Chagas disease in Spain, the United States and other non-endemic countries
-
Gascon J, Bern C, Pinazo MJ. 2010. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 115:22-27. http://dx.doi.org/10.1016/j.actatropica.2009.07.019.
-
(2010)
Acta Trop.
, vol.115
, pp. 22-27
-
-
Gascon, J.1
Bern, C.2
Pinazo, M.J.3
-
7
-
-
64049108552
-
Side effects of benznidazole as treatment in chronic Chagas disease: Fears and realities
-
Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A. 2009. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev. Anti Infect. Ther. 7:157-163. http://dx.doi.org/10.1586/14787210.7.2.157.
-
(2009)
Expert Rev. Anti Infect. Ther.
, vol.7
, pp. 157-163
-
-
Viotti, R.1
Vigliano, C.2
Lococo, B.3
Alvarez, M.G.4
Petti, M.5
Bertocchi, G.6
Armenti, A.7
-
8
-
-
73249149372
-
Use of benznidazole to treat chronic Chagas' disease: A systematic review with a meta-analysis
-
Perez-Molina JA, Perez-Ayala A, Moreno S, Fernandez-Gonzalez MC, Zamora J, Lopez-Velez R. 2009. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J. Antimicrob. Chemother. 64:1139-1147. http://dx.doi.org/10.1093/jac/dkp357.
-
(2009)
J. Antimicrob. Chemother.
, vol.64
, pp. 1139-1147
-
-
Perez-Molina, J.A.1
Perez-Ayala, A.2
Moreno, S.3
Fernandez-Gonzalez, M.C.4
Zamora, J.5
Lopez-Velez, R.6
-
9
-
-
79959793199
-
Antitrypanosomal therapy for chronic Chagas' disease
-
Bern C. 2011. Antitrypanosomal therapy for chronic Chagas' disease. N. Engl. J. Med. 364:2527-2534. http://dx.doi.org/10.1056/NEJMct11014204.
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 2527-2534
-
-
Bern, C.1
-
10
-
-
77955436769
-
New insights in Chagas' disease treatment
-
Urbina JA. 2010. New insights in Chagas' disease treatment. Drugs Future 35:409-419. http://dx.doi.org/10.1358/dof.2010.035.05.1484391.
-
(2010)
Drugs Future
, vol.35
, pp. 409-419
-
-
Urbina, J.A.1
-
11
-
-
79952059363
-
Current and developing therapeutic agents in the treatment of Chagas disease
-
Apt W. 2010. Current and developing therapeutic agents in the treatment of Chagas disease. Drug Des. Devel. Ther. 4:243-253. http://dx.doi.org/10.2147/ DDDT.58338.
-
(2010)
Drug Des. Devel. Ther.
, vol.4
, pp. 243-253
-
-
Apt, W.1
-
12
-
-
70449562088
-
New, improved treatments for Chagas disease: From the R&D pipeline to the patients
-
Ribeiro I, Sevcsik AM, Alves F, Diap G, Don R, Harhay MO, Chang S, Pecoul B. 2009. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl. Trop. Dis. 3(7):e484. http://dx.doi.org/10.1371/ journal.pntd.0000484.
-
(2009)
PLoS Negl. Trop. Dis.
, vol.3
, Issue.7
-
-
Ribeiro, I.1
Sevcsik, A.M.2
Alves, F.3
Diap, G.4
Don, R.5
Harhay, M.O.6
Chang, S.7
Pecoul, B.8
-
13
-
-
84870742537
-
Fexinidazole: A potential new drug candidate for Chagas disease
-
Bahia MT, de Andrade IM, Martins TA, do Nascimento AF, Diniz LF, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I. 2012. Fexinidazole: a potential new drug candidate for Chagas disease. PLoS Negl. Trop. Dis. 6(11):e1870. http://dx.doi.org/10.1371/journal.pntd.0001870.
-
(2012)
PLoS Negl. Trop. Dis.
, vol.6
, Issue.11
-
-
Bahia, M.T.1
De Andrade, I.M.2
Martins, T.A.3
Do Nascimento, A.F.4
Diniz, L.F.5
Caldas, I.S.6
Talvani, A.7
Trunz, B.B.8
Torreele, E.9
Ribeiro, I.10
-
14
-
-
0036234361
-
Chemotherapy of Chagas disease
-
Urbina JA. 2002. Chemotherapy of Chagas disease. Curr. Pharm. Des. 8:287-295. http://dx.doi.org/10.2174/1381612023396177.
-
(2002)
Curr. Pharm. Des.
, vol.8
, pp. 287-295
-
-
Urbina, J.A.1
-
15
-
-
0032781317
-
Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: Insights on safety, target validation, and mechanism of action
-
McKerrow JH. 1999. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action. Int. J. Parasitol. 29:833-837.
-
(1999)
Int. J. Parasitol.
, vol.29
, pp. 833-837
-
-
McKerrow, J.H.1
-
16
-
-
0036835142
-
Proteinases of Trypanosoma cruzi: Patential targets for the chemotherapy of Chagas desease
-
Cazzulo JJ. 2002. Proteinases of Trypanosoma cruzi: patential targets for the chemotherapy of Chagas desease. Curr. Top. Med. Chem. 2:1261-1271. http://dx.doi.org/10.2174/1568026023392995.
-
(2002)
Curr. Top. Med. Chem.
, vol.2
, pp. 1261-1271
-
-
Cazzulo, J.J.1
-
17
-
-
82755198904
-
The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death
-
Alvarez VE, Niemirowicz GT, Cazzulo JJ. 2012. The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death. Biochim. Biophys. Acta 1824: 195-206. http://dx.doi.org/10.1016/j.bbapap.2011.05.011.
-
(2012)
Biochim. Biophys. Acta
, vol.1824
, pp. 195-206
-
-
Alvarez, V.E.1
Niemirowicz, G.T.2
Cazzulo, J.J.3
-
19
-
-
80053321084
-
Cysteine peptidases of kinetoplastid parasites
-
Caffrey CR, Lima AP, Steverding D. 2011. Cysteine peptidases of kinetoplastid parasites. Adv. Exp. Med. Biol. 712:84-99. http://dx.doi.org/10. 1007/978-1-4419-8414-2-6.
-
(2011)
Adv. Exp. Med. Biol.
, vol.712
, pp. 84-99
-
-
Caffrey, C.R.1
Lima, A.P.2
Steverding, D.3
-
20
-
-
0032541311
-
Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection
-
Engel JC, Doyle PS, Hsieh I, McKerrow JH. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-734.
-
(1998)
J. Exp. Med.
, vol.188
, pp. 725-734
-
-
Engel, J.C.1
Doyle, P.S.2
Hsieh, I.3
McKerrow, J.H.4
-
21
-
-
35848971033
-
A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
-
Doyle PS, Zhou YM, Engel JC, McKerrow JH. 2007. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection. Antimicrob. Agents Chemother. 51:3932-3939. http://dx.doi.org/10.1128/AAC.00436- 07.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 3932-3939
-
-
Doyle, P.S.1
Zhou, Y.M.2
Engel, J.C.3
McKerrow, J.H.4
-
22
-
-
28844509592
-
A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi
-
Barr SC, Warner KL, Kornreic BG, Piscitelli J, Wolfe A, Benet L, McKerrow JH. 2005. A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrob. Agents Chemother. 49:5160-5161. http://dx.doi.org/10.1128/AAC.49.12.5160-5161.2005.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 5160-5161
-
-
Barr, S.C.1
Warner, K.L.2
Kornreic, B.G.3
Piscitelli, J.4
Wolfe, A.5
Benet, L.6
McKerrow, J.H.7
-
23
-
-
77649200180
-
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy
-
Brak K, Kerr ID, Barrett KT, Fuchi N, Debnath M, Ang K, Engel JC, McKerrow JH, Doyle PS, Brinen LS, Ellman JA. 2010. Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. J. Med. Chem. 53:1763-1773. http://dx.doi.org/10. 1021/jm901633v.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 1763-1773
-
-
Brak, K.1
Kerr, I.D.2
Barrett, K.T.3
Fuchi, N.4
Debnath, M.5
Ang, K.6
Engel, J.C.7
McKerrow, J.H.8
Doyle, P.S.9
Brinen, L.S.10
Ellman, J.A.11
-
24
-
-
33749664751
-
The consequences of lysosomotropism on the design of selective cathepsinKinhibitors
-
Black WC, Percival MD. 2006. The consequences of lysosomotropism on the design of selective cathepsinKinhibitors. Chembiochem 7:1525-1535. http://dx.doi.org/10.1002/cbic.200600149.
-
(2006)
Chembiochem
, vol.7
, pp. 1525-1535
-
-
Black, W.C.1
Percival, M.D.2
-
25
-
-
67651180563
-
Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: Two double-blind, randomized, placebo-controlled phase i studies
-
Stoch SA, Zajic S, Stone J, Miller DL, Van Dyck K, Gutierrez MJ, De Decker M, Liu L, Liu Q, Scott BB, Panebianco D, Jin B, Duong LT, Gottesdiener K, Wagner JA. 2009. Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies. Clin. Pharmacol. Ther. 86:175-182. http://dx.doi.org/10.1038/clpt.2009.60.
-
(2009)
Clin. Pharmacol. Ther.
, vol.86
, pp. 175-182
-
-
Stoch, S.A.1
Zajic, S.2
Stone, J.3
Miller, D.L.4
Van Dyck, K.5
Gutierrez, M.J.6
De Decker, M.7
Liu, L.8
Liu, Q.9
Scott, B.B.10
Panebianco, D.11
Jin, B.12
Duong, L.T.13
Gottesdiener, K.14
Wagner, J.A.15
-
26
-
-
84875295907
-
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: Safety, tolerability, pharmacokinetics and pharmacodynamics. Results from single oral dose studies in healthy volunteers
-
Stoch SA, Zajic S, Stone JA, Miller DL, van Bortel L, Lasseter KC, Pramanik B, Cilissen C, Liu Q, Liu L, Scott BB, Panebianco D, Ding Y, Gottesdiener K, Wagner JA. 2012. Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics. Results from single oral dose studies in healthy volunteers. Br. J. Clin. Pharmacol. 75:1240-1254. http://dx.doi.org/10.1111/j.1365-2125. 2012.04471.x.
-
(2012)
Br. J. Clin. Pharmacol.
, vol.75
, pp. 1240-1254
-
-
Stoch, S.A.1
Zajic, S.2
Stone, J.A.3
Miller, D.L.4
Van Bortel, L.5
Lasseter, K.C.6
Pramanik, B.7
Cilissen, C.8
Liu, Q.9
Liu, L.10
Scott, B.B.11
Panebianco, D.12
Ding, Y.13
Gottesdiener, K.14
Wagner, J.A.15
-
27
-
-
38749144762
-
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
-
Gauthier JY, Chauret N, Cromlish W, Desmarais S, l, Duong T, Falgueyret JP, Kimmel DB, Lamontagne S, Leger S, LeRiche T, Li CS, Masse F, McKay DJ, Nicoll-Griffith DA, Oballa RM, Palmer JT, Percival MD, Riendeau D, Robichaud J, Rodan GA, Rodan SB, Seto C, Therien M, Truong VL, Venuti MC, Wesolowski G, Young RN, Zamboni R, Black WC. 2008. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg. Med. Chem. Lett. 18:923-928. http://dx.doi.org/10.1016/j.bmcl.2007.12.047.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 923-928
-
-
Gauthier, J.Y.1
Chauret, N.2
Cromlish, W.3
Desmarais, S.L.4
Duong, T.5
Falgueyret, J.P.6
Kimmel, D.B.7
Lamontagne, S.8
Leger, S.9
Leriche, T.10
Li, C.S.11
Masse, F.12
McKay, D.J.13
Nicoll-Griffith, D.A.14
Oballa, R.M.15
Palmer, J.T.16
Percival, M.D.17
Riendeau, D.18
Robichaud, J.19
Rodan, G.A.20
Rodan, S.B.21
Seto, C.22
Therien, M.23
Truong, V.L.24
Venuti, M.C.25
Wesolowski, G.26
Young, R.N.27
Zamboni, R.28
Black, W.C.29
more..
-
28
-
-
84859293501
-
Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease
-
Nicoll-Griffith DA. 2012. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease. Expert Opin. Drug Discov. 7:353-366. http://dx.doi.org/10.1517/17460441.2012.668520.
-
(2012)
Expert Opin. Drug Discov.
, vol.7
, pp. 353-366
-
-
Nicoll-Griffith, D.A.1
-
29
-
-
78449283849
-
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
-
Beaulieu C, Isabel E, Fortier A, Masse F, Mellon C, Methot N, Ndao M, Nicoll-Griffith D, Lee D, Park H, Black WC. 2010. Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease. Bioorg. Med. Chem. Lett. 20:7444-7449. http://dx.doi.org/10.1016/j.bmcl.2010.10.015.
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 7444-7449
-
-
Beaulieu, C.1
Isabel, E.2
Fortier, A.3
Masse, F.4
Mellon, C.5
Methot, N.6
Ndao, M.7
Nicoll-Griffith, D.8
Lee, D.9
Park, H.10
Black, W.C.11
-
30
-
-
25144461176
-
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K
-
Black WC, Bayly CI, Davis DE, Desmarais S, Falgueyret JP, Leger S, Li CS, Masse F, McKay DJ, Palmer JT, Percival MD, Robichaud J, Tsou N, Zamboni R. 2005. Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K. Bioorg. Med. Chem. Lett. 15:4741-4744. http://dx.doi.org/10.1016/j.bmcl.2005.07. 071.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 4741-4744
-
-
Black, W.C.1
Bayly, C.I.2
Davis, D.E.3
Desmarais, S.4
Falgueyret, J.P.5
Leger, S.6
Li, C.S.7
Masse, F.8
McKay, D.J.9
Palmer, J.T.10
Percival, M.D.11
Robichaud, J.12
Tsou, N.13
Zamboni, R.14
-
31
-
-
0019862535
-
Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi
-
Baum SG, Wittner M, Nadler JP, Horwitz SB, Dennis JE, Schiff PB, Tanowitz HB. 1981. Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi. Proc. Natl. Acad. Sci. U. S. A. 78:4571-4575.
-
(1981)
Proc. Natl. Acad. Sci. U. S. A.
, vol.78
, pp. 4571-4575
-
-
Baum, S.G.1
Wittner, M.2
Nadler, J.P.3
Horwitz, S.B.4
Dennis, J.E.5
Schiff, P.B.6
Tanowitz, H.B.7
-
32
-
-
0026781519
-
The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi
-
Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS. 1992. The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J. Biol. Chem. 267:7411-7420.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 7411-7420
-
-
Eakin, A.E.1
Mills, A.A.2
Harth, G.3
McKerrow, J.H.4
Craik, C.S.5
-
33
-
-
28144452675
-
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity
-
Falgueyret JP, Desmarais S, Oballa R, Black WC, Cromlish W, Khougaz K, Lamontagne S, Masse F, Riendeau D, Toulmond S, Percival MD. 2005. Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity. J. Med. Chem. 48:7535-7543. http://dx.doi.org/10.1021/jm0504961.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 7535-7543
-
-
Falgueyret, J.P.1
Desmarais, S.2
Oballa, R.3
Black, W.C.4
Cromlish, W.5
Khougaz, K.6
Lamontagne, S.7
Masse, F.8
Riendeau, D.9
Toulmond, S.10
Percival, M.D.11
-
34
-
-
8844229444
-
An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells
-
Falgueyret JP, Black WC, Cromlish W, Desmarais S, Lamontagne S, Mellon C, Riendeau D, Rodan S, Tawa P, Wesolowski G, Bass KE, Venkatraman S, Percival MD. 2004. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells. Anal. Biochem. 335:218-227. http://dx.doi.org/10.1016/j.ab.2004.09.005.
-
(2004)
Anal. Biochem.
, vol.335
, pp. 218-227
-
-
Falgueyret, J.P.1
Black, W.C.2
Cromlish, W.3
Desmarais, S.4
Lamontagne, S.5
Mellon, C.6
Riendeau, D.7
Rodan, S.8
Tawa, P.9
Wesolowski, G.10
Bass, K.E.11
Venkatraman, S.12
Percival, M.D.13
-
35
-
-
0035912807
-
L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: Contribution of the nitric oxide and polyamine pathways
-
Piacenza L, Peluffo G, Radi R. 2001. L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways. Proc. Natl. Acad. Sci. U. S. A. 98:7301-7306. http://dx.doi.org/10. 1073/pnas.121520398.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 7301-7306
-
-
Piacenza, L.1
Peluffo, G.2
Radi, R.3
-
36
-
-
32344432042
-
Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease
-
Berrizbeitia M, Ndao M, Bubis J, Gottschalk M, Ache A, Lacouture S, Medina M, Ward BJ. 2006. Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease. J. Clin. Microbiol. 44:291-296. http://dx.doi.org/10.1128/JCM.44.2.291-296.2006.
-
(2006)
J. Clin. Microbiol.
, vol.44
, pp. 291-296
-
-
Berrizbeitia, M.1
Ndao, M.2
Bubis, J.3
Gottschalk, M.4
Ache, A.5
Lacouture, S.6
Medina, M.7
Ward, B.J.8
-
37
-
-
0035871948
-
Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: Application of robotic sample preparation and fast liquid chromatography-mass spectrometry
-
Bateman KP, Castonguay G, Xu L, Rowland S, Nicoll-Griffith DA, Kelly N, Chan CC. 2001. Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 754:245-251.
-
(2001)
J. Chromatogr. B Biomed. Sci. Appl.
, vol.754
, pp. 245-251
-
-
Bateman, K.P.1
Castonguay, G.2
Xu, L.3
Rowland, S.4
Nicoll-Griffith, D.A.5
Kelly, N.6
Chan, C.C.7
-
38
-
-
16544390350
-
Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (epimastigotes, amastigotes, and trypomastigotes) and assessment of antigen stability for the three assays
-
Berrizbietia M, Ndao M, Gottschalk M, Ache A, Vasquez F, Lacouture S, Medina M, Ward BJ. 2004. Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (epimastigotes, amastigotes, and trypomastigotes) and assessment of antigen stability for the three assays. J. Clin. Microbiol. 42:1766-1769. http://dx.doi.org/10.1128/JCM.42.4.1766-1769.2004.
-
(2004)
J. Clin. Microbiol.
, vol.42
, pp. 1766-1769
-
-
Berrizbietia, M.1
Ndao, M.2
Gottschalk, M.3
Ache, A.4
Vasquez, F.5
Lacouture, S.6
Medina, M.7
Ward, B.J.8
-
39
-
-
0017168578
-
Trypanosoma brucei: A rapid "matching" method for estimating the host's parasitemia
-
Herbert WJ, Lumsden WH. 1976. Trypanosoma brucei: a rapid "matching" method for estimating the host's parasitemia. Exp. Parasitol. 40:427-431.
-
(1976)
Exp. Parasitol.
, vol.40
, pp. 427-431
-
-
Herbert, W.J.1
Lumsden, W.H.2
-
40
-
-
43249116465
-
Drug-induced cure drives conversion to a stable and protective CD8 T central memory response in chronic Chagas disease
-
Bustamante JM, Bixby LM, Tarleton RL. 2008. Drug-induced cure drives conversion to a stable and protective CD8 T central memory response in chronic Chagas disease. Nat. Med. 14:542-550. http://dx.doi.org/10.1038/nm1744.
-
(2008)
Nat. Med.
, vol.14
, pp. 542-550
-
-
Bustamante, J.M.1
Bixby, L.M.2
Tarleton, R.L.3
-
41
-
-
0034503184
-
Trypanosoma cruzi infection of squirrel monkeys: Comparison of blood smear examination, commercial enzymelinked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries
-
Ndao M, Kelly N, Normandin D, Maclean JD, Whiteman A, Kokoskin E, Arevalo I, Ward BJ. 2000. Trypanosoma cruzi infection of squirrel monkeys: comparison of blood smear examination, commercial enzymelinked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries. Comp. Med. 50:658-665.
-
(2000)
Comp. Med.
, vol.50
, pp. 658-665
-
-
Ndao, M.1
Kelly, N.2
Normandin, D.3
Maclean, J.D.4
Whiteman, A.5
Kokoskin, E.6
Arevalo, I.7
Ward, B.J.8
-
42
-
-
33645719955
-
Treatment of experimental chronic chagas disease with trifluralin
-
Zaidenberg A, Luong T, Lirussi D, Bleiz J, Del Buono MB, Quijano G, Drut R, Kozubsky L, Marron A, Buschiazzo H. 2006. Treatment of experimental chronic chagas disease with trifluralin. Basic Clin. Pharmacol. Toxicol. 98:351-356. http://dx.doi.org/10.1111/j.1742-7843.2006.pto-253.x.
-
(2006)
Basic Clin. Pharmacol. Toxicol.
, vol.98
, pp. 351-356
-
-
Zaidenberg, A.1
Luong, T.2
Lirussi, D.3
Bleiz, J.4
Del Buono, M.B.5
Quijano, G.6
Drut, R.7
Kozubsky, L.8
Marron, A.9
Buschiazzo, H.10
-
43
-
-
77952497845
-
Hurdles in the drug discovery of cathepsin K inhibitors
-
Kometani M, Nonomura K, Tomoo T, Niwa S. 2010. Hurdles in the drug discovery of cathepsin K inhibitors. Curr. Top. Med. Chem. 10:733-744. http://dx.doi.org/10.2174/156802610791113478.
-
(2010)
Curr. Top. Med. Chem.
, vol.10
, pp. 733-744
-
-
Kometani, M.1
Nonomura, K.2
Tomoo, T.3
Niwa, S.4
-
44
-
-
13844308925
-
Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease
-
Choe Y, Brinen LS, Price MS, Engel JC, Lange M, Grisostomi C, Weston SG, Pallai PV, Cheng H, Hardy LW, Hartsough DS, McMakin M, Tilton RF, Baldino CM, Craik CS. 2005. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease. Bioorg. Med. Chem. 13:2141-2156. http://dx.doi.org/10.1016/j.bmc.2004.12.053.
-
(2005)
Bioorg. Med. Chem.
, vol.13
, pp. 2141-2156
-
-
Choe, Y.1
Brinen, L.S.2
Price, M.S.3
Engel, J.C.4
Lange, M.5
Grisostomi, C.6
Weston, S.G.7
Pallai, P.V.8
Cheng, H.9
Hardy, L.W.10
Hartsough, D.S.11
McMakin, M.12
Tilton, R.F.13
Baldino, C.M.14
Craik, C.S.15
-
45
-
-
9644265257
-
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain
-
Fujii N, Mallari JP, Hansell EJ, Mackey Z, Doyle P, Zhou YM, Gut J, Rosenthal PJ, McKerrow JH, Guy RK. 2005. Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain. Bioorg. Med. Chem. Lett. 15:121-123. http://dx.doi.org/10.1016/j.bmcl.2004.10.023.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 121-123
-
-
Fujii, N.1
Mallari, J.P.2
Hansell, E.J.3
Mackey, Z.4
Doyle, P.5
Zhou, Y.M.6
Gut, J.7
Rosenthal, P.J.8
McKerrow, J.H.9
Guy, R.K.10
-
46
-
-
2542533103
-
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi
-
Greenbaum DC, Mackey Z, Hansell E, Doyle P, Gut J, Caffrey CR, Lehrman J, Rosenthal PJ, McKerrow JH, Chibale K. 2004. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J. Med. Chem. 47:3212-3219. http://dx.doi.org/10.1021/jm030549j.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 3212-3219
-
-
Greenbaum, D.C.1
Mackey, Z.2
Hansell, E.3
Doyle, P.4
Gut, J.5
Caffrey, C.R.6
Lehrman, J.7
Rosenthal, P.J.8
McKerrow, J.H.9
Chibale, K.10
-
47
-
-
71749099614
-
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases
-
Bryant C, Kerr ID, Debnath M, Ang KK, Ratnam J, Ferreira RS, Jaishankar P, Zhao D, Arkin MR, McKerrow JH, Brinen LS, Renslo AR. 2009. Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Bioorg. Med. Chem. Lett. 19:6218-6221. http://dx.doi.org/10.1016/j.bmcl.2009.08. 098.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 6218-6221
-
-
Bryant, C.1
Kerr, I.D.2
Debnath, M.3
Ang, K.K.4
Ratnam, J.5
Ferreira, R.S.6
Jaishankar, P.7
Zhao, D.8
Arkin, M.R.9
McKerrow, J.H.10
Brinen, L.S.11
Renslo, A.R.12
-
48
-
-
79957989066
-
Mining a cathepsin inhibitor library for new antiparasitic drug leads
-
Ang KK, Ratnam J, Gut J, Legac J, Hansell E, Mackey ZB, Skrzypczynska KM, Debnath A, Engel JC, Rosenthal PJ, McKerrow JH, Arkin MR, Renslo AR. 2011. Mining a cathepsin inhibitor library for new antiparasitic drug leads. PLoS Negl. Trop. Dis. 5(5):e1023. http://dx.doi.org/10.1371/journal.pntd.001023.
-
(2011)
PLoS Negl. Trop. Dis.
, vol.5
, Issue.5
-
-
Ang, K.K.1
Ratnam, J.2
Gut, J.3
Legac, J.4
Hansell, E.5
Mackey, Z.B.6
Skrzypczynska, K.M.7
Debnath, A.8
Engel, J.C.9
Rosenthal, P.J.10
McKerrow, J.H.11
Arkin, M.R.12
Renslo, A.R.13
-
49
-
-
0026606269
-
Inhibitors of the major cysteinyl proteinase (GP57/ 51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro
-
Meirelles MN, Juliano L, Carmona E, Silva SG, Costa EM, Murta AC, Scharfstein J. 1992. Inhibitors of the major cysteinyl proteinase (GP57/ 51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 52:175-184.
-
(1992)
Mol. Biochem. Parasitol.
, vol.52
, pp. 175-184
-
-
Meirelles, M.N.1
Juliano, L.2
Carmona, E.3
Silva, S.G.4
Costa, E.M.5
Murta, A.C.6
Scharfstein, J.7
-
50
-
-
0031937742
-
Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi
-
Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, McKerrow JH. 1998. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J. Cell Sci. 111:597-606.
-
(1998)
J. Cell Sci.
, vol.111
, pp. 597-606
-
-
Engel, J.C.1
Doyle, P.S.2
Palmer, J.3
Hsieh, I.4
Bainton, D.F.5
McKerrow, J.H.6
-
51
-
-
4644357065
-
A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes
-
Aparicio IM, Scharfstein J, Lima AP. 2004. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 72:5892-5902. http://dx.doi.org/10.1128/IAI.72.10. 5892-5902.2004.
-
(2004)
Infect. Immun.
, vol.72
, pp. 5892-5902
-
-
Aparicio, I.M.1
Scharfstein, J.2
Lima, A.P.3
-
52
-
-
77950929777
-
Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists
-
Benitez-Hernandez I, Mendez-Enriquez E, Ostoa P, Fortoul T, Ramirez JA, Stempin C, Cerban F, Soldevila G, Garcia-Zepeda EA. 2010. Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists. Immunobiology 215:413-426. http://dx.doi.org/10.1016/j.imbio.2009.06.001.
-
(2010)
Immunobiology
, vol.215
, pp. 413-426
-
-
Benitez-Hernandez, I.1
Mendez-Enriquez, E.2
Ostoa, P.3
Fortoul, T.4
Ramirez, J.A.5
Stempin, C.6
Cerban, F.7
Soldevila, G.8
Garcia-Zepeda, E.A.9
-
53
-
-
84857089753
-
Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: A converging pathway leading to chagasic vasculopathy
-
Andrade D, Serra R, Svensjo E, Lima AP, Ramos ES, Jr, Fortes FS, Morandini AC, Morandi V, Soeiro MN, Tanowitz HB, Scharfstein J. 2012. Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy. Br. J. Pharmacol. 165:1333-1347. http://dx.doi.org/10.1111/j.1476-5381.2011.01609. x.
-
(2012)
Br. J. Pharmacol.
, vol.165
, pp. 1333-1347
-
-
Andrade, D.1
Serra, R.2
Svensjo, E.3
Lima, A.P.4
Ramos Jr., E.S.5
Fortes, F.S.6
Morandini, A.C.7
Morandi, V.8
Soeiro, M.N.9
Tanowitz, H.B.10
Scharfstein, J.11
-
54
-
-
84874310959
-
The kallikrein-kinin system in experimental Chagas disease: A paradigm to investigate the impact of inflammatory edema on GPCRmediated pathways of host cell invasion by Trypanosoma cruzi
-
Scharfstein J, Andrade D, Svensjo E, Oliveira AC, Nascimento CR. 2012. The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCRmediated pathways of host cell invasion by Trypanosoma cruzi. Front. Immunol. 3:396. http://dx.doi.org/10. 3389/fimmu.2012.00396.
-
(2012)
Front. Immunol.
, vol.3
, pp. 396
-
-
Scharfstein, J.1
Andrade, D.2
Svensjo, E.3
Oliveira, A.C.4
Nascimento, C.R.5
-
55
-
-
0141671823
-
Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi
-
Berasain P, Carmona C, Frangione B, Cazzulo JJ, Goni F. 2003. Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 130:23-29. http://dx.doi.org/10.1016/S0166-68511(03)00139-7.
-
(2003)
Mol. Biochem. Parasitol.
, vol.130
, pp. 23-29
-
-
Berasain, P.1
Carmona, C.2
Frangione, B.3
Cazzulo, J.J.4
Goni, F.5
-
56
-
-
80053457353
-
The Trypanosoma cruzi protease cruzain mediates immune evasion
-
Doyle PS, Zhou YM, Hsieh I, Greenbaum DC, McKerrow JH, Engel JC. 2011. The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog. 7(9):e1002139. http://dx.doi.org/10.1371/journal.ppat.1002139.
-
(2011)
PLoS Pathog.
, vol.7
, Issue.9
-
-
Doyle, P.S.1
Zhou, Y.M.2
Hsieh, I.3
Greenbaum, D.C.4
McKerrow, J.H.5
Engel, J.C.6
-
57
-
-
68949200543
-
Two approaches to discovering and developing new drugs for Chagas disease
-
McKerrow JH, Doyle PS, Engel JC, Podust LM, Robertson SA, Ferreira R, Saxton T, Arkin M, Kerr ID, Brinen LS, Craik CS. 2009. Two approaches to discovering and developing new drugs for Chagas disease. Mem. Inst. Oswaldo Cruz 104(Suppl 1):263-269. http://dx.doi.org/10.1590/S0074-02762009000900034.
-
(2009)
Mem. Inst. Oswaldo Cruz
, vol.104
, Issue.SUPPL. 1
, pp. 263-269
-
-
McKerrow, J.H.1
Doyle, P.S.2
Engel, J.C.3
Podust, L.M.4
Robertson, S.A.5
Ferreira, R.6
Saxton, T.7
Arkin, M.8
Kerr, I.D.9
Brinen, L.S.10
Craik, C.S.11
-
58
-
-
37349029510
-
Effect of cathepsin k inhibitor basicity on in vivo off-target activities
-
Desmarais S, Black WC, Oballa R, Lamontagne S, Riendeau D, Tawa P, l, Duong T, Pickarski M, Percival MD. 2008. Effect of cathepsin k inhibitor basicity on in vivo off-target activities. Mol. Pharmacol. 73:147-156. http://dx.doi.org/10.1124/mol.107.039511.
-
(2008)
Mol. Pharmacol.
, vol.73
, pp. 147-156
-
-
Desmarais, S.1
Black, W.C.2
Oballa, R.3
Lamontagne, S.4
Riendeau, D.5
Tawa, P.L.6
Duong, T.7
Pickarski, M.8
Percival, M.D.9
|